文献速递前列腺癌

三区活检方案评估前列腺融合活检靶向准确性

Use of a trizonal schema to assess targeting accuracy in prostatic fusion biopsy.
PubMed 文献 · BJU Int · 2020-02-27

该研究描述了一种新型三区活检方案,在靶向和系统活检基础上增加邻近靶区活检,以评估前列腺MRI融合系统的准确性。靶区、近靶区和MRI阴性区阳性核心比例分别为66%、39%和17%;近靶区活检使17%患者升级,9%患者仅通过近靶区活检确诊显著前列腺癌。

要点

  • 近靶区活检可提高显著前列腺癌检出率
  • 靶区阳性时近靶区77%检出显著癌
  • 9%患者仅近靶区活检确诊显著癌

核心结论

  • 三区活检方案中的近靶区活检为优化显著前列腺癌检测提供了新方法。

研究设计与样本

  • 单中心高容量机构前瞻性队列研究,2017年9月至2019年5月,纳入290例疑似前列腺癌行多参数MRI的男性,其中75例小PI-RADS 3-5病灶(<15 mm)接受三区活检。

主要发现

  • 靶区、近靶区和MRI阴性区的阳性核心百分比分别为66%、39%和17%。
  • 当靶区阳性时,近靶区在77%的病例中检出显著癌。
  • 通过增加近靶区核心,17%的参与者被升级,中位(范围)升级1(1-3)级。
  • 值得注意的是,当靶区核心阴性时,9%的男性仅通过近靶区活检核心被诊断为临床显著前列腺癌。

临床怎么用

  • 在前列腺融合活检中,除靶向和系统活检外,可考虑增加近靶区活检以提高显著前列腺癌检出率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe the use of a novel 'trizonal' biopsy schema in which 'near-target' biopsies are taken adjacent to the MRI lesion, in addition to target and systematic biopsies, to determine the accuracy of prostate MRI fusion systems. PARTICIPANTS AND METHODS: A trizonal biopsy technique was used to evaluate 75 men with small Prostate Imaging Reporting and Data System (PI-RADS) 3-5 MRI lesions (<15 mm) identified from a prospective cohort of 290 men undergoing multiparametric magnetic resonance imaging (MRI) for suspected prostate cancer at a single high-volume institution between September 2017 and May 2019. In addition to target and systematic biopsies, near-target biopsies were taken 4 mm from the apparent border of the MRI lesion. Comparisons were made between highest International Society of Urological Pathology grade and longest tumour length. RESULTS: Fifty-three men with significant prostate cancer in the same quadrant as the target were included in the final analysis. The percentages of positive cores from target, near-target and MRI-negative zones were 66%, 39% and 17%, respectively. Significant cancer was detected in the near-target zone in 77% of cases when the target zone was positive. A total of 17% of participants were upgraded by a median (range) of 1 (1-3) grades through the addition of near-target cores. Notably, 9% of men were diagnosed with clinically significant prostate cancer solely via the near-target biopsy cores when the target cores were negative. CONCLUSION: The use of near-target biopsies as part of a trizonal biopsy schema provides a novel methodology to optimize clinically significant prostate cancer detection.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Franklin A, Gianduzzo T, Yaxley J, et al. Use of a trizonal schema to assess targeting accuracy in prostatic fusion biopsy. BJU Int. 2020. PMID: 32104968. doi:10.1111/bju.14974

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。